Log in
Enquire now
‌

US Patent 7217689 Glycosylation analogs of erythropoietin

Patent 7217689 was granted and assigned to Amgen on May, 2007 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Current Assignee
Amgen
Amgen
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
72176890
Patent Inventor Names
Steven G. Elliott0
Thomas E. Byrne0
Date of Patent
May 15, 2007
0
Patent Application Number
084798920
Date Filed
June 6, 1995
0
Patent Citations Received
‌
US Patent 11944794 Drug delivery device with proximity sensor
0
‌
US Patent 12076366 Therapeutic vitamin D conjugates
0
‌
US Patent 11992659 Controllable drug delivery system and method of use
0
Patent Primary Examiner
‌
Robert C Hayes
0
Patent abstract

Erythropoietin analogs having at least one additional site for glycosylation, or a rearrangement of at least one site for glycosylation are disclosed. The invention also relates to DNA sequences encoding said erythropoietin analogs, and recombinant plasmids and host cells for analog expression.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 7217689 Glycosylation analogs of erythropoietin

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.